Medical News

RSS

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.

18 May 2010

Cancer Research UK launches new cancer centre in Leeds

LEEDS today joins a unique chain of Cancer Research UK Centres that are being launched across the UK.

18 May 2010

New research shows link between mental health and creativity

New research shows a possible explanation for the link between mental health and creativity. By studying receptors in the brain, researchers at Karolinska Institutet have managed to show that the dopamine system in healthy, highly creative people is similar in some respects to that seen in people with schizophrenia.

18 May 2010

LIFEDGE delivery system from Stand-By Systems ready for pilot scale production

Emerging Healthcare Solutions, Inc. disclosed that the Company has received documents from Stand-By Systems affirming that their revolutionary LIFEDGE prototype is now complete and ready for pilot scale production. EHSI recently executed an option with Stand-By Systems, owner of the new FDA approved SBS 1615 catalytic oxygen generator and associated systems.

18 May 2010

Abviva receives Japanese patent for Mammastatin Serum Assay

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, announced today that the Japanese Patent Office issued two patents on the core technology that may be used for therapeutic applications and in the Company's breast cancer risk assessment test, the Mammastatin Serum Assay (MSA).

18 May 2010

Uninsured patients may receive poorer quality care in Pennsylvania hospitals: Study

Adult patients without health insurance admitted to intensive care units in Pennsylvania hospitals are at a 21 percent increased risk of death compared to similar patients with private insurance, according to researchers from the University of Pennsylvania.

18 May 2010

ICU-acquired infection rates are not indication of patients' mortality risk: Researchers

ICU-acquired infection rates are not an indication of patients' mortality risk, according to researchers the University of Pennsylvania, undermining a central tenet of many pay-for-performance initiatives.

18 May 2010

Study of link between cell phone use and brain tumours inconclusive

The world's biggest investigation on possible links between cell phone use and brain tumours is inconclusive, according to a Canadian scientist who collaborated on the Interphone International Study Group. Jack Siemiatycki, a professor at the University of Montreal and an epidemiologist at the University of Montreal Hospital Research Center, says restricted access to participants compromised the validity of results of the study to be published in the May 18 International Journal of Epidemiology.

18 May 2010

Remote Presence hospital networks to accelerate patient's access to clinical stroke experts

InTouch Health, the world leader in Remote Presence Total Telemedicine solutions, is advancing stroke care by developing Remote Presence hospital networks that accelerate a patient's access to clinical stroke experts. To date, the Company has more than 25 stroke and multispecialty care networks comprised of over 300 hospital locations.

18 May 2010

Family plays vital role in children's oral health: General Dentistry

Parents are a child's first teacher in life and play a significant role in maintaining his or her overall health. Providing oral health education to mothers and families is essential to teaching children healthy habits and preventing early childhood tooth decay, according to an article published in the May/June 2010 issue of General Dentistry, the peer-reviewed clinical journal of the Academy of General Dentistry.

18 May 2010

Caliper to sell RapidTrace solid phase extraction and TurboVap evaporation product lines to Biotage for $16.5M

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that it reached an agreement to sell its RapidTrace® solid phase extraction and TurboVap® evaporation product lines to Biotage AB for $16.5 million in cash.

18 May 2010

BioSante receives two new US patents covering 2A/Furin technology for expressing proteins

BioSante Pharmaceuticals, Inc. today announced the receipt of two US new patents directed to its 2A/Furin technology for expressing proteins. The first issued US patent, US Pat. No., 7,709,224, covers methods for manufacturing recombinant antibodies. By incorporating our 2A/Furin technology into antibody-expression in viral vectors it is possible to rapidly generate stable, high producing antibody cell lines.

18 May 2010

Regular consumption of pistachios lowers risk of CHD: Study

A new nut and blood lipid study published on May 10, 2010, in Archives of Internal Medicine, led by Dr. Joan Sabate and colleagues at Loma Linda University (Loma Linda, Calif.), confirms that eating nuts, like pistachios, have a total and LDL (bad)-cholesterol-lowering effect, supporting the evidence that regular nut consumption can lower the risk of coronary heart disease.

18 May 2010

KaloBios Pharmaceuticals' KB001 promising in prevention of serious lung infection

The data from the initial clinical studies with KB001, a novel antibody fragment against PcrV on Pseudomonas aeruginosa (Pa) bioengineered by KaloBios Pharmaceuticals, Inc. and partnered with sanofi pasteur, demonstrated promising therapeutic activity in the prevention of serious lung infection in mechanically ventilated patients colonized with the bacterium and in limiting potentially damaging inflammation in patients with cystic fibrosis, where Pa plays an important role in the disease.

18 May 2010

VBI researchers establish new tree of life for gamma-proteobacteria

A new "tree of life" has been constructed by researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech for the gamma-proteobacteria, a large group of medically and scientifically important bacteria that includes Escherichia coli, Salmonella typhimurium, and other disease-causing organisms.

18 May 2010

Pelosi's statement on new guidance for small business owners in new health insurance reform law

Speaker Nancy Pelosi issued the following statement today after the Obama Administration announced new guidance to make it easier for small business owners to take advantage of tax credits in the new health insurance reform law, including clarifying that a small business' substantial tax credit under reform will not be reduced if they also receive a state subsidy, and allowing them to receive tax credits for add-on dental and vision coverage in addition to regular health insurance

18 May 2010

Helmholtz Centre for Infection Research receives "Grand Challenges Explorations" grant

The Helmholtz Centre for Infection Research (HZI) has received a grant through the current round of the funding programme "Grand Challenges Explorations" of the Bill & Melinda Gates Foundation. The programme is supporting a global health project for development of nanoparticles that release the vaccine active ingredients through the skin upon contact with perspiration.

18 May 2010

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.

18 May 2010

Article demonstrates single agent activity of KRX-0401 in neuroblastoma tumor preclinical models

Keryx Biopharmaceuticals today announced the publication of an article in the May 12th Journal of the National Cancer Institute, entitled "In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine," demonstrating the single agent activity of KRX-0401 (perifosine) in neuroblastoma tumor preclinical models.

18 May 2010

REVEAL risk score calculator provides innovative approach to better understand PAH

Actelion Ltd announced today that findings from the REVEAL Registry have confirmed the clinical utility of the REVEAL risk score calculator, a new tool designed to predict 1-year survival in patients with pulmonary arterial hypertension according to data presented at the American Thoracic Society's Annual International Conference.

18 May 2010

Medical News

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

Cancer Research UK launches new cancer centre in Leeds

New research shows link between mental health and creativity

LIFEDGE delivery system from Stand-By Systems ready for pilot scale production

Abviva receives Japanese patent for Mammastatin Serum Assay

Uninsured patients may receive poorer quality care in Pennsylvania hospitals: Study

ICU-acquired infection rates are not indication of patients' mortality risk: Researchers

Study of link between cell phone use and brain tumours inconclusive

Remote Presence hospital networks to accelerate patient's access to clinical stroke experts

Family plays vital role in children's oral health: General Dentistry

Caliper to sell RapidTrace solid phase extraction and TurboVap evaporation product lines to Biotage for $16.5M

BioSante receives two new US patents covering 2A/Furin technology for expressing proteins

Regular consumption of pistachios lowers risk of CHD: Study

KaloBios Pharmaceuticals' KB001 promising in prevention of serious lung infection

VBI researchers establish new tree of life for gamma-proteobacteria

Pelosi's statement on new guidance for small business owners in new health insurance reform law

Helmholtz Centre for Infection Research receives "Grand Challenges Explorations" grant

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Article demonstrates single agent activity of KRX-0401 in neuroblastoma tumor preclinical models

REVEAL risk score calculator provides innovative approach to better understand PAH

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News